0001169245-21-000089.txt : 20210903
0001169245-21-000089.hdr.sgml : 20210903
20210903164336
ACCESSION NUMBER: 0001169245-21-000089
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210712
FILED AS OF DATE: 20210903
DATE AS OF CHANGE: 20210903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arnold Susan Elizabeth
CENTRAL INDEX KEY: 0001755746
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38697
FILM NUMBER: 211237095
MAIL ADDRESS:
STREET 1: C/O PHASEBIO PHARMACEUTICALS, INC.
STREET 2: 1 GREAT VALLEY DRIVE, SUITE 30
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001169245
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 030375697
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY
STREET 2: SUITE 30
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (610) 981-6500
MAIL ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY
STREET 2: SUITE 30
CITY: MALVERN
STATE: PA
ZIP: 19355
FORMER COMPANY:
FORMER CONFORMED NAME: Phase Biosciences Inc
DATE OF NAME CHANGE: 20061013
FORMER COMPANY:
FORMER CONFORMED NAME: DT BIOSCIENCES INC
DATE OF NAME CHANGE: 20020315
4/A
1
wf-form4a_163070178763813.xml
FORM 4/A
X0306
4/A
2021-07-12
2021-07-14
0
0001169245
PhaseBio Pharmaceuticals Inc
PHAS
0001755746
Arnold Susan Elizabeth
C/O PHASEBIO PHARMACEUTICALS, INC.
1 GREAT VALLEY PARKWAY, SUITE 30
MALVERN
PA
19355
0
1
0
0
VP, Preclinical and Chem
Common Stock
2021-07-12
4
M
0
4519
1.74
A
27760
D
Employee Stock Option (right to buy)
1.74
2021-07-12
4
M
0
4519
0
D
2015-07-12
2021-07-12
Common Stock
4519.0
0
D
Amended to correct the transaction code for common stock acquired through stock options exercised in a transaction on July 12, 2021.
Amended to add a transaction for the exercise of stock options on July 12, 2021.
All shares underlying this option have vested.
/s/ John P. Sharp, Attorney-in-fact
2021-09-03